New Bipolar I And Schizophrenia Treatment: The US Food and Drug Administration (FDA) has approved Bysanti (Milsaperidone) made by Vanda Pharmaceuticals on 20 February 2026, for the treatment of acute ...
As temperatures rise, so do sleepless nights, medication dangers, and social isolation, compounding vulnerability for those ...
Epilepsy is one of the common disorders known to man, with early accounts of the disorder traced back to antiquity.1 It was ...
Diagnosing serious mental illnesses like schizophrenia can take up to 10 years after the first episode. As one can imagine, this can have very negative repercussions. Catching psychosis early on helps ...
A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia. A new study published in Science Advances has identified higher levels of two biological markers in ...
What Is Bysanti, and Why Does It Matter? Bysanti (milsaperidone) is a new FDA-approved oral medicine for treating certain mental health conditions in adults. It belongs to a group of medicines called ...
A new study found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain region associated with psychosis. A McGill University-led study found that people with cannabis ...
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma ASCO Guidelines provide recommendations ...
As marijuana use among teens has grown in the past decade, researchers have been trying to better understand the health risks of the drug. Now, a new longitudinal study finds that cannabis use among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results